What Makes Finch Therapeutics (FNCH) a Worthy Investment?
Finch Therapeutics: Post-Trial Decision Can Potentially Drive Shares To Trade Higher
Finch Announces Delisting from Nasdaq and SEC Deregistration
Finch Therapeutics Group to Delist from Nasdaq
Finch Therapeutics announces Nasdaq delisting, SEC deregistration
Finch Therapeutics looks to delist from the Nasdaq Global Select Market
FNCH Stock Earnings: Finch Therapeutics Gr Reported Results for Q2 2024
Finch Therapeutics CMO Zain Kassam To Step Down, Debra Silberg To Become CMO
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.
